Platelet-activating factor (PAF)-like oxidized phospholipids: Relevance to atherosclerosis

被引:25
|
作者
Tokumura, A [1 ]
Sumida, T [1 ]
Toujima, M [1 ]
Kogure, K [1 ]
Fukuzawa, K [1 ]
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan
关键词
platelet-activating factor; oxidized phosphatidylcholine; oxidized low density lipoprotein; atherosclerosis;
D O I
10.1002/biof.5520130106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid peroxidation is involved in the pathogenesis of chronic diseases including atherosclerosis. Oxidized lipoprotein has diverse biological activities and is believed to initiate atheroma formation and maturate fatty plaque. The active components of oxidized lipoproteins still remain to be clarified, but a likely candidate is the phosphatidylcholine (PC) having an sn-2-short-chain acyl group with a methyl, hydroxyl, aldehydic or carboxylic terminal. These unique PCs, formed by oxidative fragmentation of the polyunsaturated acyl group of the parent PC in liposomes, low density lipoproteins and blood plasma, induce platelet aggregation through the activation of the receptor for platelet-activating factor (PAF), due to their resemblance in structure with PAF. We have found that PAF-like lipids regulate DNA synthesis acid production of nitric oxide independently of the activation of the PAF receptor in vascular smooth muscle cells. Regulation of vascular cell function through two distinct signaling pathways mediated by PAF-like lipids provides new insight into the mechanism of induction of atherosclerosis.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [1] Generation of platelet-activating factor (PAF)-like phospholipids in blood circulation under elevated oxidative stress: Its pathological significance on atherosclerosis
    Tokumura, A
    Tuchie, A
    Imasaki, M
    Fukuzawa, K
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2003, 34 (01) : 35 - 42
  • [2] PAF-ACETHER (PLATELET-ACTIVATING FACTOR)
    BENVENISTE, J
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 355 - 358
  • [3] Platelet-activating factor and oxidized LDL
    Androulakis, N
    Aronis, P
    Tsoukatos, DC
    FREE RADICAL RESEARCH, 2003, 37 : 77 - 77
  • [4] PAF-ACETHER (PLATELET-ACTIVATING FACTOR)
    BENVENISTE, J
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1985, 13 : 11 - 18
  • [5] RELEASE OF PLATELET-ACTIVATING FACTOR (PAF) BY MACROPHAGES
    MENCIAHUERTA, JM
    BENVENISTE, J
    ANNALES D IMMUNOLOGIE, 1978, C129 (05): : 754 - 754
  • [6] CELLULAR ORIGIN OF PLATELET-ACTIVATING FACTOR (PAF)
    BENVENISTE, J
    CAMUSSI, G
    MENCIAHUERTA, JM
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1329 - 1329
  • [7] Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis
    Bansal, Amolak S.
    Chee, Ronnie
    Sumar, Nazira
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1515 - 1516
  • [8] SYNTHETIC STUDIES ON PLATELET-ACTIVATING FACTOR (PAF)
    SUEMUNE, H
    AKASHI, A
    SAKAI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1985, 33 (03) : 1055 - 1061
  • [9] Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung:: effects of hyperoxia
    Jehle, R
    Schlame, M
    Büttner, C
    Frey, B
    Sinha, P
    Rüstow, B
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1532 (1-2): : 60 - 66
  • [10] Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines
    Marathe, GK
    Davies, SS
    Harrison, KA
    Silva, AR
    Murphy, RC
    Castro-Faria-Neto, H
    Prescott, SM
    Zimmerman, GA
    McIntyre, TM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) : 28395 - 28404